Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, gene therapies, and testing services for medical devices. Its segments comprise WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It generates the majority of its revenue from the WuXi Chemistry segment. Its geographic areas are the PRC, USA, Europe, and the Rest of the world, in which it generates the majority of its revenue from the USA.
2000
41.1K+
LTM Revenue $5.5B
LTM EBITDA $1.9B
$26.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Wuxi AppTec has a last 12-month revenue of $5.5B and a last 12-month EBITDA of $1.9B.
In the most recent fiscal year, Wuxi AppTec achieved revenue of $5.5B and an EBITDA of $1.9B.
Wuxi AppTec expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Wuxi AppTec valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $5.4B | $5.5B | $5.4B | $5.5B | XXX |
Gross Profit | $1.1B | $2.0B | $2.3B | XXX | XXX |
Gross Margin | 21% | 36% | 42% | XXX | XXX |
EBITDA | $1.7B | $1.9B | $1.9B | $1.9B | XXX |
EBITDA Margin | 32% | 35% | 35% | 35% | XXX |
Net Profit | $700M | $1.2B | $1.3B | XXX | XXX |
Net Margin | 13% | 22% | 25% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Wuxi AppTec's stock price is CNY 68 (or $9).
Wuxi AppTec has current market cap of CNY 196B (or $27.0B), and EV of CNY 189B (or $26.0B).
See Wuxi AppTec trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$26.0B | $27.0B | XXX | XXX | XXX | XXX | $0.47 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Wuxi AppTec has market cap of $27.0B and EV of $26.0B.
Wuxi AppTec's trades at 4.8x LTM EV/Revenue multiple, and 13.5x LTM EBITDA.
Analysts estimate Wuxi AppTec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Wuxi AppTec and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $26.0B | XXX | XXX | XXX |
EV/Revenue | 4.8x | XXX | XXX | XXX |
EV/EBITDA | 13.7x | XXX | XXX | XXX |
P/E | 20.4x | XXX | XXX | XXX |
P/E/Growth | 1.7x | XXX | XXX | XXX |
EV/FCF | 27.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpWuxi AppTec's NTM/LTM revenue growth is 10%
Wuxi AppTec's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $16K for the same period.
Over next 12 months, Wuxi AppTec's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Wuxi AppTec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Wuxi AppTec and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -3% | XXX | XXX | XXX | XXX |
EBITDA Margin | 35% | XXX | XXX | XXX | XXX |
EBITDA Growth | -3% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 45% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $16K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
Opex to Revenue | 12% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
Suven Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Wuxi AppTec acquired XXX companies to date.
Last acquisition by Wuxi AppTec was XXXXXXXX, XXXXX XXXXX XXXXXX . Wuxi AppTec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Wuxi AppTec founded? | Wuxi AppTec was founded in 2000. |
Where is Wuxi AppTec headquartered? | Wuxi AppTec is headquartered in China. |
How many employees does Wuxi AppTec have? | As of today, Wuxi AppTec has 41.1K+ employees. |
Who is the CEO of Wuxi AppTec? | Wuxi AppTec's CEO is Mr. Edward Hu. |
Is Wuxi AppTec publicy listed? | Yes, Wuxi AppTec is a public company listed on SHG. |
What is the stock symbol of Wuxi AppTec? | Wuxi AppTec trades under 603259 ticker. |
When did Wuxi AppTec go public? | Wuxi AppTec went public in 2018. |
Who are competitors of Wuxi AppTec? | Similar companies to Wuxi AppTec include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
What is the current market cap of Wuxi AppTec? | Wuxi AppTec's current market cap is $27.0B |
What is the current revenue of Wuxi AppTec? | Wuxi AppTec's last 12-month revenue is $5.5B. |
What is the current EBITDA of Wuxi AppTec? | Wuxi AppTec's last 12-month EBITDA is $1.9B. |
What is the current EV/Revenue multiple of Wuxi AppTec? | Current revenue multiple of Wuxi AppTec is 4.8x. |
What is the current EV/EBITDA multiple of Wuxi AppTec? | Current EBITDA multiple of Wuxi AppTec is 13.5x. |
What is the current revenue growth of Wuxi AppTec? | Wuxi AppTec revenue growth between 2023 and 2024 was -3%. |
Is Wuxi AppTec profitable? | Yes, Wuxi AppTec is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.